TALK TO
A HUMAN

Drop us a note! We would love to hear from you.

c check
Thank you!
Your submission has been received!
Oops! Something went wrong while submitting the form.

What the Experts are Saying

Enterprise validated de-identification

Enterprise validated de-identification

Mendel has validated its clinical AI technology with third party statistical verification.

Mendel is the only company to validate outcomes with AI in a clinical setting

Mendel is the only company to validate outcomes with AI in a clinical setting

Mendel is the only company to validate outcomes with AI in a clinical setting.

UPDATES & NEWS — 2 MIN READ

Deloitte features Mendel in their "Intelligent Trials" Report

Deloitte features Mendel in their "Intelligent Trials" Report

Mendel.ai is improving identification of suitable cancer patients and matching to clinical trials. Mendel.ai, a US-based company founded in 2016, uses AI tools to analyse clinical data, including medical history and genetic analysis, from cancer patients. Its goal is to facilitate clinical trials in oncology research by organising and analysing RWD, and matching patients to the right clinical trials.45 They take medical data from many structured and unstructured data sets and turn these into data digitised patient journeys aligned to specific treatments. Having collected data on over 1 million journeys, its algorithm can segment patient populations by their demographic, such as how African American women with breast cancer respond to a particular drug. In essence creating in silico or patient-less trials. The AI algorithm built on these data helps trial recruitment by finding eligible patients.

The Feed

PODCAST — 33 minutes

Jason LaBonte, Chief Strategy Officer at Datavant on Patientless Podcast #006

Jason LaBonte, Chief Strategy Officer at Datavant on Patientless Podcast #006

Jason LaBonte is an executive with over 15 years of experience in leading healthcare information companies. Accomplished manager at all levels, including analyst and production staff, product management and product development teams, and executive teams.

PODCAST — 23 minutes

Mark H Goldstein, UCSF Health Hub Chairman on Patientless Podcast #005

Mark H Goldstein, UCSF Health Hub Chairman on Patientless Podcast #005

Mark Goldstein is a full-time investor and advisor, he runs a lit' seed fund and he is a partner at a Series A venture fund. He is also a Founder of UCSF Health Hub, UCSF's growth studio.

PODCAST — 32 minutes

Melisa Tucker, VP PM & Operations, Flatiron on Patientless Podcast #004

Melisa Tucker, VP PM & Operations, Flatiron on Patientless Podcast #004

Melisa Tucker, VP Product Management & Operations, Real World Evidence at Flatiron Health was our guest on Patientless Podcast.

PODCAST — 27 minutes

Richard Gliklich, CEO of OM1 on Patientless Podcast #003

Richard Gliklich, CEO of OM1 on Patientless Podcast #003

Today's guest is Dr. Richard Gliklich, he's the founder and CEO of OM1, but he's also a physician. He's a professor of Otolaryngology at Harvard medical school, and before starting OM1 he also founded a company called Outcome at around 1998. That was eventually sold to what is now known as IQVIA, and built the phase four or the outcome piece of the business. He has led several key national and international efforts focused on evaluating the safety and effectiveness and value and quality of healthcare. So we're very honored to have him today on our podcast. Richard, thank you so much and welcome to the Patientless podcast.

PODCAST — 40 minutes

Jacob LaPorte, Novartis on Patientless Podcast #002

Jacob LaPorte, Novartis on Patientless Podcast #002

Our guest is Jacob LaPorte, Co-Founder & Global Head of The BIOME by Novartis | Co-Founder/Advisor of digital health start-ups.

PODCAST — 44 minutes

Brent Clough, CEO of Trio Health on Patientless Podcast #001

Brent Clough, CEO of Trio Health on Patientless Podcast #001

Welcome to the first episode of Mendel's Patientless Podcast. Our first guest is Brent Clough, CEO of Trio Health. Brent started his career in the financial sector. He was a VP at Goldman Sachs; founded a very interesting company in healthcare: IntrinsiQ, which pretty much build the largest longitudinal patient database at the time and was later acquired. Brent is now a co-founder of Trio.

VIDEO — 8 minutes

Mendel on Hospital-to-Home by UCSF Health Hub

Mendel on Hospital-to-Home by UCSF Health Hub

Mendel's CEO Karim Galil was a guest in Hospital-to-Home by UCSF Health Hub. Karim presented how Mendel transforms EMR data and clinical literature.

Interview — 25 min

Applied AI and Race to 
a COVID-19 Vaccine

Applied AI and Race to 
a COVID-19 Vaccine

Mendel's CEO Karim Galil was a guest in Bootstrap Lab's Applied AI Insiders Series. Karim talked about race to a COVID-19 Vaccine using AI.

UPDATES & NEWS — 2 MIN READ

Mendel releases COVID-19 AI search engine

Mendel releases COVID-19 AI search engine

We’re now excited to announce our new COVID-19 AI search engine which is available to the public here. Mendel ingested and absorbed more than 50,000 scholarly articles, released by the White House, related to Coronaviruses and COVID-19. Researchers, epidemiologists, and clinicians can use this tool to ask questions about COVID-19 and glean relevant answers in seconds — a process that can take a human numerous hours, days, or even weeks to conduct.